JR, Y., L, Z., Q, G., EA, A., M, B., LN, S., . . . AR, L. (2020). Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling. Pharmaceutics, 12(11), . https://doi.org/10.3390/pharmaceutics12111003
Chicago Style (17th ed.) CitationJR, Yaron, et al. "Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling." Pharmaceutics 12, no. 11 (2020). https://doi.org/10.3390/pharmaceutics12111003.
MLA (9th ed.) CitationJR, Yaron, et al. "Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling." Pharmaceutics, vol. 12, no. 11, 2020, https://doi.org/10.3390/pharmaceutics12111003.
Warning: These citations may not always be 100% accurate.
